High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Because of its potent immunosuppressive yet stem cell–sparing activity, high-dose cyclophosphamide was tested as sole prophylaxis of graft-versus-host disease (GVHD) after myeloablative allogeneic bone marrow transplantation (alloBMT). We treated 117 patients (median age, 50 years; range, 21-66 year...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Luznik, Leo, Bolaños-Meade, Javier, Zahurak, Marianna, Chen, Allen R., Smith, B. Douglas, Brodsky, Robert, Huff, Carol Ann, Borrello, Ivan, Matsui, William, Powell, Jonathan D., Kasamon, Yvette, Goodman, Steven N., Hess, Allan, Levitsky, Hyam I., Ambinder, Richard F., Jones, Richard J., Fuchs, Ephraim J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858487/
https://ncbi.nlm.nih.gov/pubmed/20124511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-11-251595
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados